Secretory phospholipase A2 IIA is up-regulated by TNF-α and IL-1α/β after transient focal cerebral ischemia in rat

Brain Research

Volumn 1134, Issue 1, 2007, Pages 199-205

  Adibhatla, Rao Muralikrishna ^a,b,c,d   Hatcher, J F ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Cardiovascular Research Center   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Cytokines; Focal cerebral ischemia; Interleukin 1; Phosphatidylcholine; Phospholipase A2; Stroke; TNF

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTIBODY; CYTOKINE; GROUP II SECRETORY PHOSPHOLIPASE A2; MEMBRANE LIPID; PHOSPHOLIPASE A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; CONTROLLED STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT; TRANSIENT ISCHEMIC ATTACK; UPREGULATION; ANIMAL; BRAIN INFARCTION; CEREBRAL ARTERY DISEASE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENCEPHALITIS; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; NERVE DEGENERATION; PATHOPHYSIOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT;

RATTUS;

ANIMALS; ANTIBODIES; CEREBRAL INFARCTION; CYTOKINES; DOWN-REGULATION; ENCEPHALITIS; ENZYME ACTIVATION; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; ISCHEMIC ATTACK, TRANSIENT; MALE; MEMBRANE LIPIDS; NERVE DEGENERATION; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASES A; RATS; RATS, INBRED SHR; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33846359049     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.11.080     Document Type: Article

References (48)

1. 2 stimulation and hydroxyl radical generation in transient cerebral ischemia. J. Neurosci. Res. 73 (2003) 308-315
2. 2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radical Biol. Med. 40 (2006) 376-387
3. 2, hydroxyl radicals and lipid peroxidation in transient cerebral ischemia. Antioxid. Redox Signal. 5 (2003) 647-654
4. Adibhatla R.M., Hatcher J.F., and Tureyen K. CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke. Brain Res. 1058 (2005) 193-197
5. Adibhatla R.M., Hatcher J.F., and Dempsey R.J. Lipids and lipidomics in brain injury and diseases. AAPS J. 8 (2006) E314-E321
6. 2 and CTP-phosphocholine cytidylyltransferase after stroke. J. Biol. Chem. 281 (2006) 6718-6725
7. Allan S.M., and Rothwell N.J. Cytokines and acute neurodegeneration. Nat. Neurosci. 2 (2001) 734-744
8. Allan S.M., Tyrrell P.J., and Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev., Immunol. 5 (2005) 629-640
9. 2 modulates TNF-α- and IL-1β-induced NF-κB activation. J. Biol. Chem. 276 (2001) 30527-30536
10. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R., Lysko P.G., and Feuerstein G.Z. TNF-α. A mediator of focal ischemic brain injury. Stroke 28 (1997) 1233-1244
11. Boutin H., LeFeuvre R.A., Horai R., Asano M., Iwakura Y., and Rothwell N.J. Role of IL-1α and IL-1β in ischemic brain damage. J. Neurosci. 21 (2001) 5528-5534
12. Clark W.M., Rinker L.G., Lessov N.S., Hazel K., Hill J.K., Stenzel-Poore M., and Eckenstein F. Lack of IL-6 expression is not protective against focal central nervous system ischemia. Stroke 31 (2000) 1715-1720
13. Cui Z., and Houweling M. Phosphatidylcholine and cell death. Biochim. Biophys. Acta 1585 (2002) 87-96
14. Hallenbeck J.M. The many faces of TNF in stroke. Nat. Med. 8 (2002) 1363-1368
15. Hemelrijck A.V., Vermijlen D., Hachimi-Idrissi S., Sarre S., Ebinger G., and Michotte Y. Effect of resuscitative mild hypothermia on glutamate and dopamine release, apoptosis and ischaemic brain damage in the endothelin-1 rat model for focal cerebral ischaemia. J. Neurochem. 87 (2003) 66-75
16. Hosomi N., Ban C.R., Naya T., Takahashi T., Guo P., Song X.-y.R., and Kohno M. Tumor necrosis factor-α neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 25 (2005) 959-967
17. Huang J., Upadhyay U.M., and Tamargo R.l.J. Inflammation in stroke and focal cerebral ischemia. Surg. Neurol. 66 (2006) 232-245
18. Iadecola C., and Gorelick P.B. The Janus face of cyclooxygenase-2 in ischemic stroke: shifting toward downstream targets. Stroke 36 (2005) 182-185
19. Klein J. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J. Neural Transm. 107 (2000) 1027-1063
20. Lambertsen K.L., Meldgaard M., Ladeby R., and Finsen B. A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 25 (2005) 119-135
21. Lavine S.D., Hofman F.M., and Zlokovic B.V. Circulating antibody against TNF-α protects rat brain from reperfusion injury. J. Cereb. Blood Flow Metab. 18 (1998) 52-58
22. 2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain. J. Neurochem. 90 (2004) 637-645
23. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., and Feuerstein G.Z. TNF-α expression in ischemic neurons. Stroke 25 (1994) 1481-1488
24. Loddick S.A., and Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 16 (1996) 932-940
25. Lucas S.-M., Rothwell N.J., and Gibson R.M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 (2006) S232-S240
26. Mallampalli R.K., Ryan A.J., Salome R.G., and Jackowski S. TNF-α inhibits expression of CTP: phosphocholine cytidylyltransferase. J. Biol. Chem. 275 (2000) 9699-9708
27. Martin-Villalba A., Hahne M., Kleber S., Vogel J., Falk W., Schenkel J., and Krammer P.H. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ. 8 (2001) 676-686
28. 2-IIA: a new inflammatory factor for Alzheimer's disease. J. Neuroinflammation 3 28 (2006) 10.1186/1742-2094-3-28
29. Paxinos G. The Rat Nervous System. 2nd edn. (1995), Academic Press, San Diego
30. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 4th edn. (1998), Academic Press, New York
31. Rath P.C., and Aggarwal B.B. TNF-induced signaling in apoptosis. J. Clin. Immunol. 19 (1999) 350-364
32. Rothwell N.J. Cytokines-Killers in the brain?. J. Physiol. (London) 514 (1999) 3-17
33. Rothwell N.J., and Loddick S.A. Interleukin-1 and IL-1 receptor antagonist in stroke: mechanisms and potential therapeutics. In: Feuerstein G.Z. (Ed). Inflammation and Stroke (2001), Birkhauser Verlag, Basel 173-180
34. Saito K., Suyama K., Nishida K., Sei Y., and Basile A.S. Early increases in TNF-α, Il-6 and Il-1-β levels following transient cerebral ischemia in gerbil brain. Neurosci. Lett. 206 (1996) 149-152
35. Schutze S., Machleidt T., and Kronke M. The role of diacylglycerol and ceramide in TNF-α and IL-1 signal transduction. J. Leukocyte Biol. 56 (1994) 533-541
36. Shohami E., Ginis I., and Hallenbeck J.M. Dual role of TNF-α in brain injury. Cytokine Growth Factor Rev. 10 (1999) 119-130
37. Spangelo B.L., Farrimond D.D., Pompilius M., and Bowman K.-L. Interleukin-1β and thymic peptide regulation of pituitary and glial cell cytokine expression and cellular proliferation. Ann. N. Y. Acad. Sci. 917 (2000) 597-607
38. 2 expression in rat cultured astrocytes by LPS, TNF-α and IL-1β. Prog. Brain Res. 105 (1995) 231-238
39. 2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid Res. 45 (2004) 205-213
40. 2 in astrocytes: responses to oxidative stress, inflammation, and g protein-coupled receptor agonists. Mol. Neurobiol. 31 (2005) 27-42
41. Touzani O., Boutin H., Chuquet J., and Rothwell N. Potential mechanisms of IL-1 involvement in cerebral ischaemia. J. Neuroimmunol. 100 (1999) 203-215
42. Uno H., Matsuyama T., Akita H., Nishimura H., and Sugita M. Induction of TNF-α in the mouse hippocampus following transient forebrain ischemia. J. Cereb. Blood Flow Metab. 17 (1997) 491-499
43. Wang C.X., and Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog. Neurobiol. 67 (2002) 161-172
44. Wang X., Yue T.L., Barone F.C., White R.F., Gagnon R.C., and Feuerstein G.Z. Concomitant cortical expression of TNF-α and IL-1β mRNAs follows early response gene expression in transient focal ischemia. Mol. Chem. Neuropathol. 23 (1994) 103-114
45. 2 induces neuronal cell death via apoptosis. Mol. Pharmacol. 61 (2002) 114-126
46. 2 induces neuronal cell death via apoptosis. J. Neurochem. 81 (2002) 449-461
47. Yoshida H., Yanai H., Namiki Y., Fukatsu-Sasaki K., Furutani N., and Tada N. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev. 12 (2006) 9-20
48. 2 in rats. J. Histochem. Cytochem. 49 (2001) 777-782